[Mitochondrial antioxidant SkQl decreases intensity of ventricular arrhythmias caused by epinephrine]

Area of Science:

• Cardiovascular Pharmacology
• Mitochondrial Antioxidants
• Cardiac Electrophysiology

Context:

• Cardiac arrhythmia is a significant health concern.
• Epinephrine is known to induce cardiac arrhythmias.
• Mitochondrial dysfunction plays a role in cardiac pathology.

Purpose:

• To investigate the preventive effects of the novel antioxidant SkQ1 on epinephrine-induced cardiac arrhythmia in a rat model.
• To determine the effective dosage range of SkQ1 for cardioprotection.

Summary:

• Rats were pre-treated with varying doses of SkQ1 (0.02-20 µmol/kg) for two weeks before epinephrine administration.
• Epinephrine induced significant cardiac arrhythmia, characterized by ventricular extrasystoles.
• SkQ1 administration at doses of 0.5, 2, and 20 µmol/kg reduced arrhythmia intensity by 2-3 times and increased survival rates.
• Lower doses of SkQ1 (0.02-0.1 µmol/kg) showed no protective effect.

Impact:

• Mitochondrial antioxidant SkQ1 demonstrates significant cardioprotective effects against arrhythmogenic stimuli.
• SkQ1 enhances myocardial stability, offering a potential therapeutic strategy for preventing cardiac arrhythmias.
• These findings highlight the therapeutic potential of targeting mitochondrial function in cardiovascular disease.